Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Hypertension (HTN) is an important risk factor for cardiovascular disease. Considering the importance of this disease for public health, this study was designed in order to determine the prevalence, awareness, treatment, control, and risk factors of HTN in the Iranian adult population. METHODS: This cross-sectional study was conducted among 2,107 residents of Isfahan, Iran. Samples were selected through multi-stage random cluster sampling in 2015-2016. The outcome variable was HTN, determined by measuring blood pressure in the right arm via a digital arm blood pressure monitor. Awareness, treatment, and control of HTN were assessed by a validated and reliable researcher-developed questionnaire. Other demographic and clinical variables were assessed via a demographic questionnaire. RESULTS: The overall prevalence of HTN was 17.3% (18.9 and 15.5% in men and women, respectively). The prevalence of HTN increased in both genders with age. The prevalence of awareness of HTN among people with HTN was 69.2%, of whom 92.4 and 59.9% were taking medication for HTN and had controlled HTN, respectively. Logistic regression identified age, body mass index, having diabetes and hyperlipidemia, and a positive family history of HTN as determinants of awareness of HTN. CONCLUSIONS: The results showed that HTN was highly prevalent in the community, especially in men and in middle-aged and older adults. Approximately 30.8% of patients were unaware of their disease, and there was less awareness among younger adults. Despite the high frequency of taking medication to treat HTN, it was uncontrolled in more than 40.1% of patients. Health policy-makers should therefore consider appropriate preventive and therapeutic strategies for these high-risk groups.
Abstract
OBJECTIVES: Hypertension (HTN) is an important risk factor for cardiovascular disease. Considering the importance of this disease for public health, this study was designed in order to determine the prevalence, awareness, treatment, control, and risk factors of HTN in the Iranian adult population. METHODS: This cross-sectional study was conducted among 2,107 residents of Isfahan, Iran. Samples were selected through multi-stage random cluster sampling in 2015-2016. The outcome variable was HTN, determined by measuring blood pressure in the right arm via a digital arm blood pressure monitor. Awareness, treatment, and control of HTN were assessed by a validated and reliable researcher-developed questionnaire. Other demographic and clinical variables were assessed via a demographic questionnaire. RESULTS: The overall prevalence of HTN was 17.3% (18.9 and 15.5% in men and women, respectively). The prevalence of HTN increased in both genders with age. The prevalence of awareness of HTN among people with HTN was 69.2%, of whom 92.4 and 59.9% were taking medication for HTN and had controlled HTN, respectively. Logistic regression identified age, body mass index, having diabetes and hyperlipidemia, and a positive family history of HTN as determinants of awareness of HTN. CONCLUSIONS: The results showed that HTN was highly prevalent in the community, especially in men and in middle-aged and older adults. Approximately 30.8% of patients were unaware of their disease, and there was less awareness among younger adults. Despite the high frequency of taking medication to treat HTN, it was uncontrolled in more than 40.1% of patients. Health policy-makers should therefore consider appropriate preventive and therapeutic strategies for these high-risk groups.
참고문헌 (42)
- Go AS, "Executive summary: heart disease and stroke statistics-- 2013 update: a report from the American Heart Association", Circulation, 127, pp.143~152 (2013)[DOI]
- Lim SS, "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2224~2260 (2012)[DOI]
- Mostafavi A, "Prevalence of cardiac risk factors in ischemic stroke in a university medical center in Tehran", Iran Heart J, 17, pp.57~63 (2016)
- Hu SS, "Outline of the report on cardiovascular disease in China, 2010", Biomed Environ Sci, 25, pp.251~256 (2012)
- "A global brief on hypertension: silent killer, global public health crisis"[URL]
- "World Health Day 2013: measure your blood pressure, reduce your risk"[URL]
- Robitaille C, "Diagnosed hypertension in Canada: incidence, prevalence and associated mortality", CMAJ, 184, pp.E49~E56 (2012)[DOI]
- Sarrafzadegan N, "The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study", Saudi Med J, 33, pp.533~540 (2012)
- Musaiger AO, "Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region", Int J Gen Med, 5, pp.199~217 (2012)
- Chow CK, "Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries", JAMA, 310, pp.959~968 (2013)[DOI]
- Ghorbani R, "Prevalence of hypertension among the adult population of Semnan province", Iran J Endocrinol Metab, pp.498~503 (2009)
- Malekzadeh MM, "Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population", J Hypertens, 31, pp.1364~1371 (2013)[DOI]
- Song IH, "Effects of a hypertension management program by Seongcheon primary health care post in South Korea: an analysis of changes in the level of knowledge of hypertension in the period from 2004 to 2009", Health Educ Res, 27, pp.411~423 (2012)[DOI]
- Eghbali-Babadi M, "Design and implementation of a combined observational and interventional study: trends of prevalence, awareness, treatment and control hypertension and the effect of expanded chronic care model on control, treatment and self-care", ARYA Atheroscler, 13, pp.211~220 (2017)
- Hackam DG, "The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension", Can J Cardiol, 29, pp.528~542 (2013)[DOI]
- Gee ME, "Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee", J Clin Hypertens (Greenwich), 16, pp.773~781 (2014)[DOI]
- Hansen TW, "Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations", Hypertension, 55, pp.1049~1057 (2010)[DOI]
- Parati G, "Blood pressure variability: its measurement and significance in hypertension", J Hypertens Suppl, 23, pp.S19~S25 (2005)[DOI]
- "WHO STEPS surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance"[URL]
- Nikooyeh B, "Prevalence of obesity and overweight and its associated factors in urban adults from West Azerbaijan, Iran: the National Food and Nutritional Surveillance Program (NFNSP)", Nutr Food Sci Res, 3, pp.21~26 (2016)[DOI]
- Garawi F, "Global differences between women and men in the prevalence of obesity: is there an association with gender inequality?", Eur J Clin Nutr, 68, pp.1101~1106 (2014)[DOI]
- Ebrahimi M, "Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006", J Hypertens, 28, pp.1620~1629 (2010)[DOI]
- Mule G, "Metabolic syndrome in hypertensive patients: an unholy alliance", World J Cardiol, 6, pp.890~907 (2014)[DOI]
- Gharipour M, "Socioeconomic characteristics and controlled hypertension: evidence from Isfahan Healthy Heart Program", ARYA Atheroscler, 9, pp.77~81 (2013)
- Tabrizi JS, "Prevalence and associated factors of prehypertension and hypertension in Iranian population: the Lifestyle Promotion Project (LPP)", PLoS One, 11, pp.e0165264~ (2016)[DOI]
- Rashidipour A, "Prevalence of obesity and some related factors in 30-70 year-old population of Semnan province, Iran", J Isfahan Med Sch, 26(Suppl), pp.516~528 (2009)
- Mirzaei M, "Prevalence of hypertension in Iran 1980-2012: a systematic review", J Tehran Heart Cent, 11, pp.159~167 (2016)
- Choi HM, "Sex differences in hypertension prevalence and control: analysis of the 2010-2014 Korea National Health and Nutrition Examination Survey", PLoS One, 12, pp.e0178334~ (2017)[DOI]
- Haghdoost AA, "Epidemiology and heterogeneity of hypertension in Iran: a systematic review", Arch Iran Med, 11, pp.444~452 (2008)
- Zhou Y, "Prevalence and risk factors of hypertension among pre- and post-menopausal women: a cross-sectional study in a rural area of northeast China", Maturitas, 80, pp.282~287 (2015)[DOI]
- Shirani AK, "The causes of failure to control hypertension in population aged over 65", J Qazvin Univ Med Sci, 35, pp.8~14 (2005)
- Khosravi A, "The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan Healthy Heart Program", BMC Cardiovasc Disord, 10, pp.61~ (2010)[DOI]
- Sarrafzadegan N, "The Isfahan cohort study: rationale, methods and main findings", J Hum Hypertens, 25, pp.545~553 (2011)[DOI]
- Sabouhi F, "Knowledge, awareness, attitudes and practice about hypertension in hypertensive patients referring to public health care centers in Khoor & Biabanak", Iran J Nurs Midwifery Res, 16, pp.34~40 (2011)
- Neuhauser HK, "Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11", J Hum Hypertens, 29, pp.247~253 (2015)[DOI]
- McAlister FA, "Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades", CMAJ, 183, pp.1007~1013 (2011)[DOI]
- Nwankwo T, "Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012", NCHS Data Brief, pp.1~8 (2013)
- Sarraf-Zadegan N, "Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience", Acta Cardiol, 58, pp.309~320 (2003)[DOI]
- Sadeghi M, "Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme", Med J Malaysia, 59, pp.460~467 (2004)
- Talaei M, "Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study", Arch Iran Med, 16, pp.138~144 (2013)
- Noohi F, "The first Iranian recommendations on prevention, evaluation and management of high blood pressure", ARYA Atheroscler, 8, pp.97~118 (2012)
- Campbell NR, "High blood pressure: why prevention and control are urgent and important: a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension", J Clin Hypertens (Greenwich), 16, pp.551~553 (2014)[DOI]